跳至主要内容
临床试验/NCT05118997
NCT05118997招募中不适用

Active Removal of IntraCerebral Hematoma Via Active Irrigation of the Ventricular System

IRRAS1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年10月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
Efficacy and safety of evacuation of intraventricular hematoma by Active External Ventricular Drainage (IRRAflow) with tPA administration compared to Passive External Ventricular Drainage (EVD) with tPA administration.

研究概览

简要总结

Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular hemorrhage compared with passive drainage.

详细描述

The ARCH study is an international prospective, controlled, randomized, multicenter study to evaluate the hypothesis that active irrigation with IRRAflow® will reduce the time needed for clearance of intraventricular and intracerebral blood from intraventricular and intracerebral space compared with passive drainage and administration of tPA. This might affect the patient neurological outcome assessed by GCS and mRankin scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age >18 years of age
  • •Need of EVD
  • •Active treatment
  • •Signed informed consent obtained
  • •a. Based on institutional and country laws
  • •Spontaneous ICH with maximum 30 square cm's
  • •If needed, normal coagulation profile (PT, PTT, platelet count)
  • •Treatment within 72 hours of ictus
  • •Ability to administer 2.0 mg of tPA per day for 3 days

排除标准

  • •Age < 18 years
  • •No need of EVD
  • •Patient has fixed and dilated pupils
  • •Coagulopathy uncorrectable
  • •Vascular pathology (e.g. Aneurysm involvement, AVM involvement)
  • •Pregnant women

研究组 & 干预措施

Treatment Arm #1

Experimental

IRRAflow with manual tPA administration followed by Active Fluid Exchange

干预措施: IRRAflow (Device)

Treatment Arm #2

Experimental

IRRAflow with continuous infusion of tPA combined with Active Fluid Exchange

干预措施: IRRAflow (Device)

Treatment Arm #3

Active Comparator

Standard EVD with manual tPA administration

干预措施: EVD (Device)

结局指标

主要结局

Efficacy and safety of evacuation of intraventricular hematoma by Active External Ventricular Drainage (IRRAflow) with tPA administration compared to Passive External Ventricular Drainage (EVD) with tPA administration.

时间窗: Intra-procedure

Efficacy is defined as the efficiency of each arm to remove the hematoma (70% cm3). Safety is measured as the frequency of bacterial central nervous system (measures as positive bacterial growth in cerebrospinal fluid), symptomatic brain bleeds (clinical symptoms drop in modified Rankin scale), and mortality (death).

Radiographic evaluation of ventricular blood removal as measured by head CT scan

时间窗: Intra-procedure

Change in blood volume (cm3) measured between stability scan and end of treatment scan.

Comparison of patient outcome between groups at as measured by the Glasgow Coma Scale, extended Glasgow Outcome Scale, modified Rankin Scale.

时间窗: 0-30 days post discharge from hospital

Defined as the comparison of patients outcomes between the three groups as measured by Glasgow Coma Scale, extended Glasgow Outcome Scale, and modified Rankin Scale.

次要结局

  • Technical Success(Intra-Procedural)
  • Procedural Success(Intra-Procedural)
  • Safety - Catheter misplacement(Intra-Procedural)
  • Safety - Infection(Intra-Procedural)
  • Safety - Bleeding events(Intra-Procedural)

研究者

发起方
IRRAS
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验